Recommendations for the management of herpes zoster

Robert H. Dworkin; Robert W. Johnson; Judith Breuer; John W. Gnann; Myron J. Levin; Miroslav Backonja; Robert F. Betts; Anne A. Gershon; Maija L. Haanpää; Michael W. McKendrick; Turo J. Nurmikko; Anne Louise Oaklander; Michael N. Oxman; Deborah Pavan-Langston; Karin L. Petersen; Michael C. Rowbotham; Kenneth E. Schmader; Brett R. Stacey; Stephen K. Tyring; Albert J.M. Van Wijck; Mark S. Wallace; Sawko W. Wassilew; Richard J. Whitley

doi:10.1086/510206

Recommendations for the management of herpes zoster

Robert H. Dworkin, Robert W. Johnson, Judith Breuer, John W. Gnann, Myron J. Levin, Miroslav Backonja, Robert F. Betts, Anne A. Gershon, Maija L. Haanpää, Michael W. McKendrick, Turo J. Nurmikko, Anne Louise Oaklander, Michael N. Oxman, Deborah Pavan-Langston, Karin L. Petersen, Michael C. Rowbotham, Kenneth E. Schmader, Brett R. Stacey, Stephen K. Tyring, Albert J.M. Van WijckMark S. Wallace, Sawko W. Wassilew, Richard J. Whitley

Anesthesiology & Perioperative Medicine

Research output: Contribution to journal › Review article

478 Scopus citations

Abstract

The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.

Original language	English (US)
Pages (from-to)	S1-S26
Journal	Clinical Infectious Diseases
Volume	44
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1086/510206
State	Published - Jan 1 2007

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/510206

Fingerprint Dive into the research topics of 'Recommendations for the management of herpes zoster'. Together they form a unique fingerprint.

Cite this

Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., Nurmikko, T. J., Oaklander, A. L., Oxman, M. N., Pavan-Langston, D., Petersen, K. L., Rowbotham, M. C., Schmader, K. E., Stacey, B. R., Tyring, S. K., ... Whitley, R. J. (2007). Recommendations for the management of herpes zoster. Clinical Infectious Diseases, 44(SUPPL. 1), S1-S26. https://doi.org/10.1086/510206

Recommendations for the management of herpes zoster. / Dworkin, Robert H.; Johnson, Robert W.; Breuer, Judith; Gnann, John W.; Levin, Myron J.; Backonja, Miroslav; Betts, Robert F.; Gershon, Anne A.; Haanpää, Maija L.; McKendrick, Michael W.; Nurmikko, Turo J.; Oaklander, Anne Louise; Oxman, Michael N.; Pavan-Langston, Deborah; Petersen, Karin L.; Rowbotham, Michael C.; Schmader, Kenneth E.; Stacey, Brett R.; Tyring, Stephen K.; Van Wijck, Albert J.M.; Wallace, Mark S.; Wassilew, Sawko W.; Whitley, Richard J.

In: Clinical Infectious Diseases, Vol. 44, No. SUPPL. 1, 01.01.2007, p. S1-S26.

Research output: Contribution to journal › Review article

Dworkin, RH, Johnson, RW, Breuer, J, Gnann, JW, Levin, MJ, Backonja, M, Betts, RF, Gershon, AA, Haanpää, ML, McKendrick, MW, Nurmikko, TJ, Oaklander, AL, Oxman, MN, Pavan-Langston, D, Petersen, KL, Rowbotham, MC, Schmader, KE, Stacey, BR, Tyring, SK, Van Wijck, AJM, Wallace, MS, Wassilew, SW & Whitley, RJ 2007, 'Recommendations for the management of herpes zoster', Clinical Infectious Diseases, vol. 44, no. SUPPL. 1, pp. S1-S26. https://doi.org/10.1086/510206

Dworkin, Robert H. ; Johnson, Robert W. ; Breuer, Judith ; Gnann, John W. ; Levin, Myron J. ; Backonja, Miroslav ; Betts, Robert F. ; Gershon, Anne A. ; Haanpää, Maija L. ; McKendrick, Michael W. ; Nurmikko, Turo J. ; Oaklander, Anne Louise ; Oxman, Michael N. ; Pavan-Langston, Deborah ; Petersen, Karin L. ; Rowbotham, Michael C. ; Schmader, Kenneth E. ; Stacey, Brett R. ; Tyring, Stephen K. ; Van Wijck, Albert J.M. ; Wallace, Mark S. ; Wassilew, Sawko W. ; Whitley, Richard J. / Recommendations for the management of herpes zoster. In: Clinical Infectious Diseases. 2007 ; Vol. 44, No. SUPPL. 1. pp. S1-S26.

@article{cfc5e142806d438d8910b04e1782036d,

title = "Recommendations for the management of herpes zoster",

abstract = "The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.",

author = "Dworkin, {Robert H.} and Johnson, {Robert W.} and Judith Breuer and Gnann, {John W.} and Levin, {Myron J.} and Miroslav Backonja and Betts, {Robert F.} and Gershon, {Anne A.} and Haanp{\"a}{\"a}, {Maija L.} and McKendrick, {Michael W.} and Nurmikko, {Turo J.} and Oaklander, {Anne Louise} and Oxman, {Michael N.} and Deborah Pavan-Langston and Petersen, {Karin L.} and Rowbotham, {Michael C.} and Schmader, {Kenneth E.} and Stacey, {Brett R.} and Tyring, {Stephen K.} and {Van Wijck}, {Albert J.M.} and Wallace, {Mark S.} and Wassilew, {Sawko W.} and Whitley, {Richard J.}",

year = "2007",

month = jan,

day = "1",

doi = "10.1086/510206",

language = "English (US)",

volume = "44",

pages = "S1--S26",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Recommendations for the management of herpes zoster

AU - Dworkin, Robert H.

AU - Johnson, Robert W.

AU - Breuer, Judith

AU - Gnann, John W.

AU - Levin, Myron J.

AU - Backonja, Miroslav

AU - Betts, Robert F.

AU - Gershon, Anne A.

AU - Haanpää, Maija L.

AU - McKendrick, Michael W.

AU - Nurmikko, Turo J.

AU - Oaklander, Anne Louise

AU - Oxman, Michael N.

AU - Pavan-Langston, Deborah

AU - Petersen, Karin L.

AU - Rowbotham, Michael C.

AU - Schmader, Kenneth E.

AU - Stacey, Brett R.

AU - Tyring, Stephen K.

AU - Van Wijck, Albert J.M.

AU - Wallace, Mark S.

AU - Wassilew, Sawko W.

AU - Whitley, Richard J.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.

AB - The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.

UR - http://www.scopus.com/inward/record.url?scp=33845634835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845634835&partnerID=8YFLogxK

U2 - 10.1086/510206

DO - 10.1086/510206

M3 - Review article

C2 - 17143845

AN - SCOPUS:33845634835

VL - 44

SP - S1-S26

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 1

ER -